USA: The REVERSE-LC research study now has a website.

This study is being done "to see if an FDA-approved drug called #Baricitinib which is already used to treat #COVID, can help improve thinking and memory problems and reduce fatigue for people who have #LongCOVID."

Includes a link for those who wish to participate in the study

https://www.reversinglongcovid.org/

@longcovid #PwLC #PostCovidSyndrome #LC #PASC #postcovid
#CovidBrain
@covid19 #COVID19 #COVID_19 #SARSCoV2

"How long COVID could lift the fog on neurocognitive disorders"

There is now ample evidence that both older and younger people with long COVID and other infection-associated chronic conditions are at risk of developing ADRD (Alzheimer’s disease and related dementias). As a result, the NIH and other institutions around the world have begun to expand the scope of dementia research to include long COVID under the funding umbrella of ADRD.

https://www.nature.com/articles/d41586-024-03047-4

#LongCOVID #COVID #baricitinib

I'm now keeping an eye on: The SmPC for Olumiant 1mg Film-Coated Tablets

🏭Eli Lilly and Company Limited

💊💉 #baricitinib.

I will let you know if it changes.

🌐 https://www.medicines.org.uk/emc/product/15625/smpc